Estimating the Share of Sickness Absence Costs in Europe's GDP – A Country, Gender and Time Perspective

Katarzyna M. Miszczyńska; Elżbieta Antczak; Valentina Prevolnik Rupel

doi:10.18778/2391-6478.S1.2023.01

Authors

Katarzyna M. Miszczyńska University of Lodz, Faculty of Economics and Sociology, Department of Banking https://orcid.org/0000-0003-4924-7605
Elżbieta Antczak University of Lodz, Faculty of Economics and Sociology, Department of Spatial Econometrics https://orcid.org/0000-0002-9695-6300
Valentina Prevolnik Rupel Institute for Economic Research (IRF) Slovenia

DOI:

https://doi.org/10.18778/2391-6478.S1.2023.01

Keywords:

cost-of-illness studies, indirect costs of illness, absenteeism, human capital approach

Abstract

The purpose of the article. The aim of the study was to calculate and evaluate the costs of employee sickness absence in European countries over the period 2006–2020. An additional objective was to analyse the sensitivity of the development of absenteeism costs depending on the changing level of the discount rate used in economic evaluation analyses.

Methodology. The estimation and subsequent assessment of absenteeism of working-age people costs was based on human-capital approach and was carried out retrospectively using the morbidity, top-down approach, based on aggregated epidemiological data. As a measure of production loss volume, GDP per working person was adopted.

Results of the research. The study indicated that there is variation in the cost of sickness absence across European countries, but no clustering relationship was identified from a geographic perspective. In addition, SACS is in the range of 1,9% – 2,1% in all countries in 2006 prices.

Downloads

Download data is not yet available.

References

Acemoglu, D., Johnson S. (2007). Disease and development: The effect of life expectancy on economic growth. Journal of Political Economy, 115(6), pp. 925–985. https://doi.org/10.1086/529000 DOI: https://doi.org/10.1086/529000

Anselin L., Florax R. J. (1995), New Directions in Spatial Econometrics, Springer Science & Business Media, http://dx.doi.org/10.1007/978-3-642-79877-1 DOI: https://doi.org/10.1007/978-3-642-79877-1

Antczak E., Miszczyńska, K. (2021), Causes of sickness absenteeism in Europe – analysis from an intercountry and gender perspective, International Journal of Environmental Research and Public Health, 18(22), https://doi.org/10.3390/ijerph182211823 DOI: https://doi.org/10.3390/ijerph182211823

Bloom D., Kotschy R., Prettner K., Canning D., Schünemann J. (2022), Health and Economic Growth: Reconciling the Micro and Macro Evidence, CESifo Working Paper, No. 9806, https://doi.org/10.2139/ssrn.4148203 DOI: https://doi.org/10.2139/ssrn.4148203

Brodszky V., Beretzky Z., Baji P., Rencz F., Péntek M., Rotar A., Tachkov K., Mayer S., Simon J., Niewada M., Hren R., Gulácsi L. (2019), Cost-of-illness studies in nine Central and Eastern European countries, European Journal of Health Economics, 20(s1), pp. 155–172, https://doi.org/10.1007/s10198-019-01066-x DOI: https://doi.org/10.1007/s10198-019-01066-x

Cleemput I., Neyt M., Van de Sande S., Thiry N. (2015), Belgian Guidelines for Economic Evaluations and Budget Impact Analyses, Second Edition.

Drummond M., Sculpher M., Torrance G. (2005), Methods for the economic evaluation of health care programmes (3rd edition). DOI: https://doi.org/10.1093/oso/9780198529446.001.0001

Ernst&Young (2013), Metodyka pomiaru kosztów pośrednich w polskim systemie ochrony zdrowia.

European Comm (2022), Euro area and EU working days to build Calendar Adjustment Regressor.

Haacker M., Hallett T. B., Atun, R. (2020), On discount rates for economic evaluations in global health, Health Policy and Planning, 35(1), pp. 107–114, https://doi.org/10.1093/heapol/czz127 DOI: https://doi.org/10.1093/heapol/czaa073

Javaid K., Neidhardt M., Reynolds T., Cullen A., Anderson C. L., Long J., Manhart L., Anderson L., Investigator P. (2008), Morbidity and Economic Growth, Evans School Policy Analysis & Research Group (EPAR), Issue 293.

Jiang S., Wang Y., Si L., Zang X., Gu Y. Y., Jiang Y., Li, G. G., Wu, J. (2022), Incorporating productivity loss in health economic evaluations: A review of guidelines and practices worldwide for research agenda in China, BMJ Global Health, 7(8), pp. 1–14, https://doi.org/10.1136/bmjgh-2022-009777 DOI: https://doi.org/10.1136/bmjgh-2022-009777

Jo C. (2014), Cost-of-illness studies: concepts, scopes, and methods Clinical and Molecular Hepatology, pp. 327–337, http://dx.doi.org/10.3350/cmh.2014.20.4.327 DOI: https://doi.org/10.3350/cmh.2014.20.4.327

Koopmanschap M., Rutten F., van Ineveld B., van Roijen L. (1995), The friction cost method for measuring indirect costs of disease, Journal of Health Economics, 14(2), pp. 171–189, http://dx.doi.org/10.1016/0167-6296(94)00044-5 DOI: https://doi.org/10.1016/0167-6296(94)00044-5

Krol M., Brouwer W., Rutten, F. (2013), Productivity costs in economic evaluations: past, present, future. PharmacoEconomic, 31, pp. 537–54, https://doi.org/10.1007/s40273-013-0056-3 DOI: https://doi.org/10.1007/s40273-013-0056-3

Kujawska J. (2015), Absencja chorobowa – szacunek niewytworzonego PKB, Studia Ekonomiczne, 214(214), pp. 264–275.

Kukuła K., Bogocz D. (2014), Zero Unitarization Method and its Application in Ranking Research in Agriculture, Economic and Regional Studies, 7(3), pp. 5–13.

Lotrič Dolinar A., Zvan, B., Došenović Bonča P. (2020), Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data, Zdravstveno Varstvo, 59(2), pp. 75–82, https://doi.org/10.2478/sjph-2020-0010 DOI: https://doi.org/10.2478/sjph-2020-0010

Lublóy Á. (2019), Economic burden of migraine in Latvia and Lithuania : direct and indirect costs, https://doi.org/10.1186/s12889-019-7461-2 DOI: https://doi.org/10.1186/s12889-019-7461-2

Łyszczarz B., Nojszewska E. (2017), Productivity losses and public finance burden attributable to breast cancer in Poland, BMC Cancer, http://doi.org/10.1186/s12885-017-3669-7 DOI: https://doi.org/10.1186/s12885-017-3669-7

Mennini F. S., Gitto, L. (2022), Approaches To Estimating Indirect Costs in Healthcare: Motivations for Choice, Journal of European Economy, Vol, 21, No. 1, pp. 17–45. https://doi.org/10.35774/jee2022.01.017 DOI: https://doi.org/10.35774/jee2022.01.017

Nachar N. (2008), The Mann-Whitney U: A Test for Assessing Whether Two Independent Samples Come from the Same Distribution, Tutorials in Quantitative Methods for Psychology, https://doi.org/10.20982/tqmp.04.1.p013 DOI: https://doi.org/10.20982/tqmp.04.1.p013

Neubauer S., Welte R., Beiche A., Koenig H. H., Buesch K., Leidl R. (2006), Mortality, morbidity and costs attributable to smoking in Germany: Update and a 10-year comparison, Tobacco Control, 15(6), https://doi.org/10.1136/tc.2006.016030 DOI: https://doi.org/10.1136/tc.2006.016030

Nicholas J. A., Electricwala B., Lee L. K., Johnson K. M. (2019), Burden of relapsing-remitting multiple sclerosis on workers in the US: A cross-sectional analysis of survey data, BMC Neurology, 19(1), pp. 1–13, https://doi.org/10.1186/s12883-019-1495-z DOI: https://doi.org/10.1186/s12883-019-1495-z

Nojszewska E. (2016), Ocena strat ekonomicznych i kosztów leczenia nowotworów piersi, szyjki macicy i jajnika w Polsce, Instytut Innowacyjna Gospodarka.

OECD (2023), Employment by activity, https://doi.org/10.1787/a258bb52-en DOI: https://doi.org/10.1787/a258bb52-en

Pederzoli V., Gandini, P. [eds] (2008), Analisi comparata sui costi dei laboratori di analisi di alcune strutture sanitarie: un’indagine per la determinazione dei costi delle prestazioni erogate https://www.icareviareggio.it/wp-content/uploads/ [Accessed: 14.02.2024]

Puddu L., Rainero C., Scagliola L., Lusa C. (2016), La certificazione dei processi amministrativi nelle aziende sanitarie, Giappichelli Editore.

Rodríguez-Sánchez B., Daugbjerg S., Peña-Longobardo L. M., Oliva-Moreno J., Aranda-Reneo I., Cicchetti A., López-Bastida J. (2022), Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease, European Journal of Health Economics, Springer Berlin Heidelberg, https://doi.org/10.1007/s10198-022-01471-9 DOI: https://doi.org/10.1007/s10198-022-01471-9

SBU (2015), Methods for health economic evaluations – A guideline based on current practices in Europe, EUnetHTA, https://www.eunethta.eu/ [Accessed: 14.02.2024]

Schultz T. (1961), Investment in Human Capital, The American Economic Review, 15(1), pp. 1–17.

Soekhai V., de Bekker-Grob E. W., Ellis A. R., Vass C. M. (2019), Discrete Choice Experiments in Health Economics: Past, Present and Future, PharmacoEconomics, 37(2), pp. 201–226, https://doi.org/10.1007/s40273-018-0734-2 DOI: https://doi.org/10.1007/s40273-018-0734-2

Tarricone R. (2006), Cost-of-illness analysis: what room in health economics?, Health Policy, pp. 51–63, https://doi.org/10.1016/j.healthpol.2005.07.016 DOI: https://doi.org/10.1016/j.healthpol.2005.07.016

Williams A. O., Rojanasarot S., McGovern A. M., Kumar A. (2023), A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications, Journal of Comparative Effectiveness Research, 12(2), https://doi.org/10.2217/cer-2022-0167 DOI: https://doi.org/10.2217/cer-2022-0167

World Bank (2022), How are aggregate growth rates computed for National Accounts series?, https://datahelpdesk.worldbank.org/knowledgebase/articles/ [Accessed: 14.02.2024].

World Bank (2023), International Comparison Program https://data.worldbank.org/ [Accessed: 14.02.2024].

World Health Organization (2022), European. Data Warehouse-European Health for All database (HFA-DB) https://gateway.euro.who.int/ [Accessed: 14.02.2024]

Zemedikun D. T., Kigozi J., Wynne-Jones G., Guariglia A., Roberts, T. (2021), Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review, PLoS ONE, pp. 1–17, https://doi.org/10.1371/journal.pone.0251406 DOI: https://doi.org/10.1371/journal.pone.0251406